Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
After-Hours Stock Movers 12/14: (DDR) (HES) (DISCA) Higher; (VSTM) (APHB) (ORCL) Lower (more...)
-
UPDATE: Cantor Fitzgerald Starts Rigel Pharmaceuticals (RIGL) at Overweight
-
Global Blood Therapeutics (GBT) Announces Proposed $100M Share Common Offering
-
Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
-
BGC Partners Updates Terms For Newmark Group IPO Roadshow
-
UPDATE: Corbus Pharmaceuticals (CRBP) PT Raised to $28 at Cantor Fitzgerald
-
Cantor Fitzgerald Remains Sidelined on Teva Pharma (TEVA) Following Announced Restructuring Plan
-
Orchid Island Capital Announces December 2017 Monthly Dividend and November 30, 2017 RMBS Portfolio Characteristics
-
Amarin (AMRN): AHA Showed OTC Fish Oil Inferior to FDA Approved Products and May Have Negative Effects - Cantor Fitzgerald
-
Cantor Fitzgerald Starts Aimmune Therapeutics (AIMT) at Overweight
-
U.S. yields rise as producer price data offsets 30-year auction
-
Colony NorthStar (CLNS) Signs LOI with S2K Regarding Combination With its Broker-dealer, NorthStar Securities
-
Colony NorthStar to Combine Retail Distribution Business with S2K Financial Holdings
-
Coupa Software (COUP) PT Raised to $38 at Cantor Fitzgerald Following 'Successful' Analyst Day
-
Pershing Gold Announces Bought Deal of US$6.8 Million and Private Placement of US$6.8 Million
-
Pershing Gold (PGLC) Announces $6.8M Common Stock and Warrant Bought Deal
-
Pershing Gold Announces Bought Deal of $6.8 Million
-
Revance Announces Closing of Public Offering of Common Stock
-
ProPhotonix Director/PDMR Dealings and Equity
-
Verisk Analytics (VRSK) PT Raised to $108 at Cantor Fitzgerald Following Investor Day
-
bluebird bio (BLUE) PT Raised to $113 at Cantor Fitzgerald, 'Believes in the Science But Not the Valuation'
-
Revance Therapeutics (RVNC) Prices 5.34M Offering of Common Stock at $31/Share
-
Revance Announces Pricing of Public Offering of Common Stock
-
Cantor Fitzgerald Starts Exela Technologies (XELA) at Overweight
-
Cantor Fitzgerald Starts Strongbridge Biopharma (SBBP) at Overweight Noting Undervalued Shares
-
Omnicell (OMCL) PT Raised to $60 at Cantor Fitzgerald, 'New Product Announcements Improve Growth Outlook'
-
Heron Therapeutics (HRTX) Prices $150M Common Stock Offering
-
Heron Therapeutics Announces Pricing of Public Offering of Common Stock
-
ProPhotonix Announces Application for Block Admission
-
Heron Therapeutics (HRTX) Plans Public Offering of Common Stock
-
Heron Therapeutics Announces Public Offering of Common Stock
-
BGC Partners (BGCP) Announces Launch of Newmark Group (NMRK) IPO Roadshow
-
BGC Partners Announces Launch Of Newmark Group IPO Roadshow
-
Northern Trust Appoints Head of ETF Capital Markets for FlexShares
-
Freddie Mac Prices $637 Million Seniors Housing Multifamily K Certificates
-
McEwen Mining Announces Timmins Exploration Program and Funding
-
Cantor Fitzgerald Sees ~4.9M Shares of Teva (TEVA) Being Bought Amid TASE Index Rebalance
-
Euronext Expands Its Federal Model with the Acquisition of the Irish Stock Exchange
-
Cantor Fitzgerald Starts Xencor, Inc. (XNCR) at Overweight
-
Cantor Fitzgerald Reiterates Overweight on UnitedHealth Group (UNH)
-
Legacy Acquisition Corp. Class A Common Stock And Warrants To Commence Trading Separately On November 30, 2017
-
JVB Financial Announces New Hires
-
Corbus Pharmaceuticals Holdings, Inc. Announces Exercise of Option to Purchase Additional Shares in Public Offering
-
UPDATE: Cantor Fitzgerald Downgrades Cytokinetics (CYTK) to Neutral
-
Ardelyx, Inc (ARDX) PT Lowered to $12 at Cantor Fitzgerald
-
Legacy Acquisition Corp. Announces Closing of $300,000,000 Initial Public Offering
-
Cantor Fitzgerald Maintains Bullish View on Synergy Pharmaceuticals (SGYP) Into Jan 24 PDUFA
-
AxoGen Announces Closing of Public Offering of Common Stock
-
PayPal (PYPL) PT Raised to $85 at Cantor Fitzgerald; Reiterates Overweight
-
Luxoft Holding (LXFT): Results In Line with Expectations, PT To $52 - Cantor Fitzgerald

